Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WYE
|
|||
| Former ID |
DIB013545
|
|||
| Drug Name |
NST-001
|
|||
| Synonyms |
Gacyclidine; Gacyclidine (nanoparticle implant, tinnitus), NeuroSystec Corp; NMDA antagonist (nanoparticle implant, tinnitus), NeuroSystec Corp; NMDA receptor antagonist (nanoparticle implant, tinnitus), NeuroSystec Corp
Click to Show/Hide
|
|||
| Indication | Tinnitus [ICD-11: MC41; ICD-10: H93.1] | Phase 1 | [1] | |
| Company |
DURECT Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00957788) Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.